Neal D Shore Selected Research

Castration

4/2024	Deep and Durable Prostate-specific Antigen Response to Darolutamide with Androgen Deprivation Therapy and Docetaxel, and Association with Clinical Outcomes for Patients with High- or Low-volume Metastatic Hormone-sensitive Prostate Cancer: Analyses of the Randomized Phase 3 ARASENS Study.
4/2024	Correction: A multidisciplinary approach to address unmet needs in the management of patients with non-metastatic castration-resistant prostate cancer.
3/2024	First-line combination treatment with PARP and androgen receptor-signaling inhibitors in HRR-deficient mCRPC: Applying clinical study findings to clinical practice in the United States.
3/2024	A global phase II randomized trial comparing oral taxane ModraDoc006/r to intravenous docetaxel in metastatic castration resistant prostate cancer.
3/2024	Efficacy and Safety of Radiotherapy Plus Relugolix in Men With Localized or Advanced Prostate Cancer.
3/2024	A multidisciplinary approach to address unmet needs in the management of patients with non-metastatic castration-resistant prostate cancer.
2/2024	Extended Safety and Tolerability of Darolutamide for Nonmetastatic Castration-Resistant Prostate Cancer and Adverse Event Time Course in ARAMIS.
1/2024	Publisher Correction: First-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer: the phase 3 TALAPRO-2 trial.
12/2023	First-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer: the phase 3 TALAPRO-2 trial.
11/2023	Pembrolizumab and Enzalutamide in Patients with Abiraterone Acetate-Pretreated Metastatic Castration-Resistant Prostate Cancer: Cohort C of the Phase 1b/2 KEYNOTE-365 Study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Neal D Shore Research Topics

Disease

143	Prostatic Neoplasms (Prostate Cancer) 05/2024 - 10/2003
38	Neoplasms (Cancer) 03/2024 - 01/2012
23	Neoplasm Metastasis (Metastasis) 03/2024 - 07/2010
16	Disease Progression 04/2024 - 11/2014
14	Pain (Aches) 01/2023 - 09/2012
12	Fatigue 02/2024 - 09/2012
9	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 09/2021 - 05/2008
7	Non-Muscle Invasive Bladder Neoplasms 05/2024 - 10/2017
6	Lower Urinary Tract Symptoms 09/2021 - 01/2016
5	Urinary Bladder Neoplasms (Bladder Cancer) 05/2024 - 01/2012
5	Hypertension (High Blood Pressure) 03/2024 - 02/2015
4	Cardiovascular Diseases (Cardiovascular Disease) 11/2023 - 01/2018
3	Neutropenia 12/2023 - 01/2020
3	Dysuria 01/2023 - 05/2008
3	Urinary Retention 01/2023 - 10/2003
3	Adenocarcinoma 02/2017 - 12/2008
2	Carcinoma in Situ 05/2024 - 03/2024
2	Headache (Headaches) 03/2024 - 07/2010
2	Atrial Fibrillation 03/2024 - 01/2018
2	Anemia 12/2023 - 01/2020
2	Chronic Disease (Chronic Diseases) 10/2023 - 12/2019
2	Injection Site Reaction 01/2022 - 12/2008
2	Circulating Neoplastic Cells 01/2020 - 01/2019
2	Infections 01/2019 - 09/2015
2	Back Pain (Backache) 01/2018 - 02/2016
2	Urinary Tract Infections (Urinary Tract Infection) 01/2018 - 12/2008
2	Diarrhea 10/2014 - 09/2012
1	Alopecia (Baldness) 03/2024
1	Urologic Neoplasms (Urological Cancer) 03/2024
1	COVID-19 12/2023
1	Exanthema (Rash) 11/2023
1	Gynecomastia 01/2022
1	Cognitive Dysfunction 10/2021

Drug/Important Bio-Agent (IBA)

49	AndrogensIBA 05/2024 - 12/2008
42	enzalutamideIBA 04/2024 - 09/2012
24	Prostate-Specific Antigen (Semenogelase)IBA 04/2024 - 12/2008
23	Hormones (Hormone)IBA 05/2024 - 12/2008
20	Androgen Receptors (Androgen Receptor)IBA 03/2024 - 09/2012
20	Testosterone (Sustanon)FDA Link 12/2023 - 12/2008
19	Leuprolide (Lupron)FDA LinkGeneric 03/2024 - 12/2008
17	sipuleucel-T (APC8015)FDA Link 01/2023 - 07/2010
15	Abiraterone AcetateIBA 11/2023 - 11/2014
14	Gonadotropin-Releasing Hormone (GnRH)FDA Link 03/2024 - 12/2008
12	relugolixIBA 03/2024 - 01/2020
11	Docetaxel (Taxotere)FDA Link 04/2024 - 06/2015
11	darolutamideIBA 04/2024 - 06/2017
11	Prednisone (Sone)FDA LinkGeneric 01/2021 - 11/2014
10	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2012
9	abirateroneIBA 11/2023 - 05/2014
6	talazoparibIBA 01/2024 - 02/2022
6	Radium-223IBA 06/2023 - 05/2014
5	apalutamideIBA 03/2024 - 12/2016
5	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 11/2023 - 01/2020
5	SteamIBA 09/2021 - 01/2016
5	AntigensIBA 01/2020 - 02/2015
4	acetyl- 2- naphthylalanyl- 3- chlorophenylalanyl- 1- oxohexadecyl- seryl- 4- aminophenylalanyl(hydroorotyl)- 4- aminophenylalanyl(carbamoyl)- leucyl- ILys- prolyl- alaninamide FDA Link 03/2024 - 12/2008
4	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2023 - 01/2021
4	bicalutamide (Casodex)FDA LinkGeneric 09/2018 - 02/2016
3	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 03/2024 - 10/2023
3	Mitomycin (Mitomycin-C)FDA LinkGeneric 10/2023 - 01/2022
3	VaccinesIBA 01/2016 - 04/2012
3	cabazitaxel FDA Link 12/2015 - 05/2014
2	pembrolizumabIBA 05/2024 - 11/2023
2	DNA (Deoxyribonucleic Acid)IBA 09/2022 - 01/2012
2	salicylhydroxamic acid (SHAM)IBA 09/2021 - 06/2017
2	antiarrhythmic peptide (AAP)IBA 01/2021 - 07/2017
2	RadiumIBA 10/2020 - 12/2015
2	PSMA ADCIBA 01/2020 - 01/2019
2	PROSTVACIBA 01/2019 - 01/2014
2	Androgen Receptor AntagonistsIBA 01/2018 - 12/2016
2	dimemorfan (AT 17)IBA 10/2017 - 01/2016
2	Zoledronic Acid (Zometa)FDA Link 12/2016 - 08/2012
2	IpilimumabIBA 05/2015 - 02/2015
1	taxaneIBA 03/2024
1	Immune Checkpoint InhibitorsIBA 01/2024
1	Dihydrotachysterol (AT 10)IBA 12/2023
1	Gemcitabine FDA Link 10/2023
1	Androgen Antagonists (Antiandrogens)IBA 01/2023
1	menthyl 3-(2-pyridylsulfinyl)acrylateIBA 01/2023
1	Phosphotransferases (Kinase)IBA 01/2022
1	LY3023414IBA 01/2022
1	DNA-Activated Protein KinaseIBA 01/2022
1	AntibodiesIBA 01/2022
1	EstetrolIBA 06/2021

Therapy/Procedure

88	Castration 04/2024 - 07/2010
87	Therapeutics 05/2024 - 03/2007
18	Drug Therapy (Chemotherapy) 03/2024 - 09/2012
17	Immunotherapy 03/2024 - 07/2010
9	Radiotherapy 03/2024 - 01/2014
6	Aftercare (After-Treatment) 09/2023 - 01/2017
4	Transurethral Resection of Bladder 01/2024 - 01/2022
3	Cystectomy 05/2024 - 10/2017
3	Injections 11/2023 - 01/2020
3	Drug Tapering 01/2023 - 05/2018
3	Prostatectomy (Retropubic Prostatectomy) 01/2023 - 05/2017
2	Orchiectomy (Orchidectomy) 03/2020 - 02/2016
2	Intramuscular Injections 09/2013 - 04/2010
2	Stents 05/2008 - 03/2007
1	Precision Medicine 11/2022
1	General Anesthesia 01/2022